Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|November 16, 2020
Human Endogenous Retrovirus Expression Is Upregulated in the Breast Cancer Microenvironment of HIV Infected Women: A Pilot StudyGislaine Curty, Greta A Beckerle, Luis P Iñiguez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2024
Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial UpdateAfshin Dowlati, Horst-Dieter Hummel, Stephane Champiat, et al.
Targeted Oncology|December 11, 2025
Beyond Proton Pump Inhibitors: Evaluating Treatment Strategies for Immune-Mediated Gastroenteritis from Cancer ImmunotherapyCarolina Colli Cruz, Maria Julia Moura Nascimento Santos, Sharada Wali, et al.
JCO Precision Oncology|May 30, 2024
Impact of Clonal Hematopoiesis-Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING TrialJulieta Rodriguez, Capucine Baldini, Arnaud Bayle, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 10, 2025
Disease Outcomes in Immune-Mediated Colitis: A Study Describing Initial Endoscopic and Histologic Presentations and Treatment OptionsMalek Shatila, Carolina Colli Cruz, Kei Takigawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2025
Phase 1 and 2 Clinical Studies of the STING Agonist Ulevostinag With and Without Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors or LymphomasKevin J Harrington, Stephane Champiat, Joshua D Brody, et al.
Cell Reports. Medicine|February 11, 2025
Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancersStephane Champiat, Elena Garralda, Vladimir Galvao, et al.
Cancer Research Communications|August 27, 2025
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase 1 UnitCamila Braganca Xavier, Clark R Andersen, JoAnn Lim, et al.
BMJ Supportive & Palliative Care|August 30, 2022
PALLIA 10 score in phase I cancer studiesKaïssa Ouali, Christine Mateus, Arianne Laparra, et al.
Plos One|July 7, 2012
Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infectionStephane Champiat, Rui André Saraiva Raposo, Nicholas J Maness, et al.
Pageof 5